biotech
Family office quietly building up a huge portfolio of investments helped by the pandemic
Most billion-dollar-plus family offices have flourished during the pandemic as private and public asset…
If the boom in biotech IPOs is over family offices won’t be happy
A recent surge in biotech IPOs haven’t quite met investor expectations raising some concerns about f…
N&Q: Family office deals, family business acquisitions, notable nextgen joins family business
Family Capital's weekly look at the goings-ons in the world of family capital
Family offices and the biotech nexus – one big deal and others await
Some big family offices are backing biotech - some are making money, others aren't
High profile biotech startup gets funding from family offices and UK aristocrat
Dragonfly Therapeutics could be big...and make its investors a pretty sum